FDA Should Lift Iressa Restrictions, Washington Legal Foundation Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Study data that aggregate the experience of many patients do not reflect the value of gefinitib in certain subgroups, WLF says in comments to the agency.